Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tengborn

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Thrombosis and Haemostasis|March 1, 1995
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteersB I Eriksson, K Söderberg, L Widlund, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Anaphylactoid reactions and nephrotic syndrome--a considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothersL Tengborn, S Hansson, A Fasth, et al.
Metabolism: Clinical and Experimental|October 1, 1990
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1K Landin, L Stigendal, E Eriksson, et al.
Journal of Internal Medicine|February 1, 1995
Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study GroupS Agewall, B Fagerberg, S Attvall, et al.
The Journal of Bone and Joint Surgery. American Volume|April 1, 1991
Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparinB I Eriksson, P Kälebo, B A Anthymyr, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1993
Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypassB Liu, A Belboul, G Rådberg, et al.
The Annals of Thoracic Surgery|June 1, 1995
Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operationsB Liu, L Tengborn, G Larson, et al.
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusingG Leone, V De Stefano, R Ferrelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Heparin-induced thrombocytopenia during continuous haemofiltrationO Samuelsson, J Amiral, P O Attman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 1999
Comparison of various D-dimer tests for the diagnosis of deep venous thrombosisK Wåhlander, L Tengborn, M Hellström, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Thrombosis and Haemostasis|March 1, 1995
A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteersB I Eriksson, K Söderberg, L Widlund, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Anaphylactoid reactions and nephrotic syndrome--a considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothersL Tengborn, S Hansson, A Fasth, et al.
Metabolism: Clinical and Experimental|October 1, 1990
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1K Landin, L Stigendal, E Eriksson, et al.
Journal of Internal Medicine|February 1, 1995
Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study GroupS Agewall, B Fagerberg, S Attvall, et al.
The Journal of Bone and Joint Surgery. American Volume|April 1, 1991
Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparinB I Eriksson, P Kälebo, B A Anthymyr, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1993
Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypassB Liu, A Belboul, G Rådberg, et al.
The Annals of Thoracic Surgery|June 1, 1995
Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operationsB Liu, L Tengborn, G Larson, et al.
Thrombosis and Haemostasis|August 30, 1988
Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusingG Leone, V De Stefano, R Ferrelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Heparin-induced thrombocytopenia during continuous haemofiltrationO Samuelsson, J Amiral, P O Attman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 1999
Comparison of various D-dimer tests for the diagnosis of deep venous thrombosisK Wåhlander, L Tengborn, M Hellström, et al.
Pageof 10